Considering the absence of leukemia blasts in the peripheral blood and bone marrow in isolated EM‐ALL patients, the questions of whether CAR T cells can successfully expand in these patients and whether these patients can benefit from CD19 CAR T therapy remain unanswered. The gene discussed is CD19; the disease is acute lymphoblastic leukemia.